Date: March 22-23 @ National Institute of Health Campus, Bethesda, MD
I’ll be attending and presenting at the Marijuana and Cannabinoids: A Neuroscience Research Conference (link) focused on “on the neurological and psychiatric effects of marijuana, other cannabinoids, and the endocannabinoid system. Both the adverse and the potential therapeutic effects of the cannabinoid system will be discussed. The goal of this summit is to ensure evidence-based information is available to inform practice and policy, particularly important at this time given the rapidly shifting landscape regarding the recreational and medicinal use of marijuana.”
I’ll be presenting my poster, “What is the Current and Future Demand for Medical Marijuana?: Trends in Medical Marijuana Use by Selected Qualifying Conditions Compared across Nine U.S. States” Despite medical marijuana first being allowed in California in 1996, there is little data on how many people are using marijuana for certain qualifying conditions, like cancer, HIV/AIDS, epilepsy, multiple sclerosis, post-traumatic stress disorder (PTSD), or chronic pain. Using public data from state medical marijuana registries, I’m trying to estimate and compare the prevalence and trends over time in medical marijuana use for selected qualifying medical conditions. By looking at these trends, we might be able to estimate future demand and better prepare allocation of funding resources for research and public health.
Click on the image below to download a copy of my poster:
What is the Current and Future Demand for Medical Marijuana?: Trends in Medical Marijuana Use by Selected Qualifying Conditions Compared Across Nine US States
